Grace TherapeuticsGRCE
13F holders, Q3 2025 (September 30)At the end of Q3 2025, 20 institutions reported holding Grace Therapeutics Inc. (GRCE) in their 13F filings, unchanged from Q2 2025. 2 opened new positions and 2 sold out. The largest holders were Nantahala Capital Management, LLC ($3.5M), AIGH Capital Management LLC ($2.7M) and Bank of America Corp. ($1.5M). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Grace Therapeutics Inc.
- CUSIP
- 00439U104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $42K |
| Exits | 2 | $144K |
All 13F filers, Q2 2025 → Q3 2025: 247,804 shares bought and 358,457 shares sold, net −110,653 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 20 holders
| Nantahala Capital Management, LLC | 0.22% | No change | 1,178,203 | $3.5M |
| AIGH Capital Management LLC | 0.95% | Reduce -19.6% | 907,217 | $2.7M |
| Bank of America Corp. | 0.00% | No change | 494,698 | $1.5M |
| Vanguard Group Inc. | 0.00% | No change | 409,100 | $1.2M |
| ADAR1 Capital Management, LLC | 0.10% | Add +98.4% | 350,450 | $1.0M |
| Stonepine Capital Management, LLC | 0.51% | Reduce -27.9% | 211,010 | $628K |
| Renaissance Technologies | 0.00% | Add +206.1% | 84,561 | $252K |
| Citadel Advisors | 0.00% | Reduce -20.7% | 27,265 | $81K |
| Millington Financial Advisors, LLC | 0.03% | No change | 20,000 | $60K |
| SeaCrest Wealth Management, LLC | 0.00% | New | 14,000 | $42K |
| Citigroup Inc. | 0.00% | Add +275600.0% | 2,757 | $8K |
| National Bank of Canada | 0.00% | No change | 2,716 | $8K |
| Morgan Stanley | 0.00% | No change | 1,848 | $6K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +19.2% | 1,610 | $5K |
| Royal Bank of Canada | 0.00% | Add +5.2% | 571 | $2K |
| Activest Wealth Management | 0.00% | No change | 104 | $310 |
| SBI Securities Co., Ltd. | 0.00% | No change | 101 | $301 |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 41 | $122 |
| Lanark Financial, Inc. | 0.00% | New | 2 | $5 |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 1 | $3 |
"% of holder's portfolio" is GRCE's weight in each manager's 13F, not the share of Grace Therapeutics Inc. the manager owns.